This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1085-99. doi: 10.1074/mcp.M900381-MCP200. Epub 2010 Feb 1.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
PLoS One. 2012;7(10):e46822. doi: 10.1371/journal.pone.0046822. Epub 2012 Oct 8.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Proteomics. 2013 Jul;13(14):2125-34. doi: 10.1002/pmic.201200323.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600432.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600432.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Insulin mediated activation of PI3K/Akt signalling pathway modifies the proteomic cargo of extracellular vesicles.
Proteomics. 2017 Aug 26. doi: 10.1002/pmic.201600371.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Insulin mediated activation of PI3K/Akt signalling pathway modifies the proteomic cargo of extracellular vesicles.
Proteomics. 2017 Aug 26. doi: 10.1002/pmic.201600371.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Comprehensive proteomics analysis of exosomes derived from human seminal plasma.
Andrology. 2017 Sep;5(5):1007-1015. doi: 10.1111/andr.12412.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.
Sci Rep. 2017 Oct 6;7(1):12782. doi: 10.1038/s41598-017-13092-x.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
COG2016104 / 0 / 104
Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies)Q9ULC4Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
COG2016104 / 0 / 104
[1]